Final Thoughts GLP-1 medications are transforming diabetes and weight management in 2026, but dialysis patients require specialized care and close monitoring
Caroline Apovian, a Professor of Medicine at Harvard Medical School and the co-director of the Center for Weight Management and Wellness at Brigham and Womens Hospital, told Healthline
It is also not recommended for people with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Kim KA, Kim YS, Park SH, Chung WJ, Choi DH, Jang ES, et al
Source: GoodhealthRx The use of GLP-1 therapies for weight loss is inhibiting access to advanced diabetes care
Laboratory Qualifications: The QC laboratory should possess CNAS/ISO 17025 accreditation, be staffed with experienced analysts, and implement a complete SOP system and data integrity management (compliant with ALCOA+ principles)